Cargando…
A33 EFFECTS OF THE NEXT GENERATION PROBIOTIC, AKKERMANSIA MUCINIPHILA, ON INTESTINAL INFLAMMATION AND BARRIER FUNCTION
BACKGROUND: Inflammatory bowel disease (IBD), characterised by chronic intestinal inflammation, is hypothesised to arise from the interplay between susceptibility genes, the immune system, environmental factors, and gut microbiota. Akkermansia muciniphila is a symbiotic bacterium that accounts for 1...
Autores principales: | Grondin, J, Wang, H, Haq, S, Kwon, Y H, MacNeil, L, Surette, M, Khan, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991313/ http://dx.doi.org/10.1093/jcag/gwac036.033 |
Ejemplares similares
-
Akkermansia muciniphila is a promising probiotic
por: Zhang, Ting, et al.
Publicado: (2019) -
The Intestinal Effect of Atorvastatin: Akkermansia muciniphila and Barrier Function
por: Cheng, Tingting, et al.
Publicado: (2022) -
A next-generation beneficial microbe: Akkermansia muciniphila
por: Naito, Yuji, et al.
Publicado: (2018) -
Next-Generation Beneficial Microbes: The Case of Akkermansia muciniphila
por: Cani, Patrice D., et al.
Publicado: (2017) -
Insights into the Antimicrobial Resistance Profile of a Next Generation Probiotic Akkermansia muciniphila DSM 22959
por: Machado, Daniela, et al.
Publicado: (2022)